Advertisement
GPAT 2024

GPAT 2024 Registration is Live Now! Find Direct Application Link Here

Our Correspondent
Posted on 19 Apr 2024
16:39 PM
File Image
Summary
The National Board of Examinations in Medical Sciences (NBEMS) has declared the commencement of the registration process for the much-anticipated Graduate Pharmacy Aptitude Test (GPAT) 2024.
The registration window will be functional till May 8 (11.55 PM).

The National Board of Examinations in Medical Sciences (NBEMS) in an official notification released today, i.e., April 19 has declared the commencement of the registration process for the much-anticipated Graduate Pharmacy Aptitude Test (GPAT) 2024. Interested candidates can start submitting their applications through the official website - natboard.edu.in. The registration window will be functional till May 8 (11.55 PM). 

How to apply

Advertisement

Candidates will be able to edit/rectify the information on the application form from May 11 to May 14, 2024.

Application Fees

Candidates belonging to the General, OBC, and EWS categories will have to pay an amount of ₹3500, whereas, SC, ST, and PwD categories will pay a reduced amount of ₹2500 as their application fee.

Find the direct application link here.  

GPAT 2024 will be conducted on June 8, 2024, for students aspiring to pursue a Master of Pharmacy (M.Pharm) degree at institutes/colleges/universities across India for the academic year 2024-2025.

Last updated on 19 Apr 2024
04:40 PM
GPAT 2024 National Board of Examinations in Medical Sciences (NBEMS) Graduate Pharmacy Aptitude Test Master of Pharmacy (MPharm) Registration
Advertisement
Similar stories
Madhyamik 2024

Kalimpong tops in West Bengal Madhyamik Exam Pass Percentage - Full District-wise lis. . .

AP ICET 2024

Admit Cards for AP ICET 2024 Out: Easy Steps to Download Hall Tickets Inside

NCET 2024

NCET 2024 Registration Last Date Extended! Check all Major Application Details Here

Madhyamik 2024

Madhyamik Exam 2024: WBBSE opens application window for scrutiny, review of answer sh. . .

read next